 Interval report phase I-II study multiple modalities treatment invasive bladder cancer bladder-sparing trial Clinicians Massachusetts General Hospital cycles methotrexate cisplatin vinblastine MCV radiotherapy cisplatin patients muscle-invasive bladder cancer Eleven patients protocol overall toxicity formidable total patients alive patients series full treatment protocol survival rate months interim analysis treatment limited success lives bladders